These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis. Kasper DL; Winkelhake JL; Zollinger WD; Brandt BL; Artenstein MS J Immunol; 1973 Jan; 110(1):262-8. PubMed ID: 4346607 [No Abstract] [Full Text] [Related]
3. Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92. Glode MP; Robbins JB; Liu TY; Gotschlich EC; Orskov I; Orskov F J Infect Dis; 1977 Jan; 135(1):94-104. PubMed ID: 64575 [TBL] [Abstract][Full Text] [Related]
4. Cross-reactions between Neisseria meningitidis group H and Escherichia coli K2 and K62 polysaccharides. van Alphen L; Arends A; Hopman C J Clin Microbiol; 1988 Feb; 26(2):394-6. PubMed ID: 3125224 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of immunotherapeutic approaches for the potential treatment of infections caused by K1-positive Escherichia coli. Cross AS; Zollinger W; Mandrell R; Gemski P; Sadoff J J Infect Dis; 1983 Jan; 147(1):68-76. PubMed ID: 6401788 [TBL] [Abstract][Full Text] [Related]
11. Immunological studies of an antigen common to many gram-negative bacteria with special reference to E. coli. Characterization and biological significance. Kaijser B Int Arch Allergy Appl Immunol; 1975; 48(1):72-81. PubMed ID: 803931 [TBL] [Abstract][Full Text] [Related]
12. Letter: Susceptibility to group B meningococcal vs. Escherichia coli K1 disease. Ericsson CD N Engl J Med; 1975 Apr; 292(14):755. PubMed ID: 803639 [No Abstract] [Full Text] [Related]
13. Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1. Devi SJ; Robbins JB; Schneerson R Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7175-9. PubMed ID: 1908091 [TBL] [Abstract][Full Text] [Related]
14. Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3. Robbins JB; Myerowitz L; Whisnant JK; Argaman M; Schneerson R; Handzel ZT; Gotschlich EC Infect Immun; 1972 Nov; 6(5):651-6. PubMed ID: 4118016 [TBL] [Abstract][Full Text] [Related]
15. Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies. Guirguis N; Schneerson R; Bax A; Egan W; Robbins JB; Shiloach J; Orskov I; Orskov F; el Kholy A J Exp Med; 1985 Dec; 162(6):1837-51. PubMed ID: 3934317 [TBL] [Abstract][Full Text] [Related]
16. Unique intermolecular bactericidal epitope involving the homosialopolysaccharide capsule on the cell surface of group B Neisseria meningitidis and Escherichia coli K1. Jennings HJ; Gamian A; Michon F; Ashton FE J Immunol; 1989 May; 142(10):3585-91. PubMed ID: 2469720 [TBL] [Abstract][Full Text] [Related]
17. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development. Jennings HJ Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499 [No Abstract] [Full Text] [Related]
18. Immunoprotective extracellular polysaccharides of Klebsiella aerogenes capsular type K1, expressed in Escherichia coli. Roe EA; Jones RJ; Saunders JR FEMS Microbiol Immunol; 1989 Apr; 1(5):253-61. PubMed ID: 2517220 [TBL] [Abstract][Full Text] [Related]
19. Screening for cross-reacting capsular polysaccharide K antigens of Escherichia coli using antiserum agar. Counts GW; Turck M J Clin Microbiol; 1977 Apr; 5(4):490-1. PubMed ID: 404319 [TBL] [Abstract][Full Text] [Related]
20. Identification of a subgroup antigen on the Neisseria meningitidis group C capsular polysaccharide. Apicella MA J Infect Dis; 1974 Feb; 129(2):147-53. PubMed ID: 4129826 [No Abstract] [Full Text] [Related] [Next] [New Search]